期刊文献+

中国肿瘤人群防控的策略与前景 被引量:3

原文传递
导出
摘要 2011年9月,联合国召开高级别大会并发布了共识文件。首次正式宣布,以心血管疾病、肿瘤、糖尿病和慢性呼吸系统疾病在内的非传染性疾病的全球负担和威胁,是21世纪发展的重大挑战之一,可破坏世界各地的社会和经济发展。
作者 乔友林
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第7期483-485,共3页 Chinese Journal of Oncology
关键词 肿瘤 人群 预防 发展中国家 Neoplasms Population-based Prevention Developing countries
  • 相关文献

参考文献9

  • 1Editorial. Two days in New York: reflections on the UN NCD summit. Lancet Oncol, 2011, 12:981.
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127: 2893-2917.
  • 3Leaf C. Why were losing the war on cancer (and how to win it). Fortune, 2004, 149:76-82, 84-6, 88.
  • 4de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 2012 [2012-05-181. http://www, sciencedirect, corn/ science/article/pii/S1470204512701377. [published online ahead of print May 8, 2012].
  • 5乔友林,张林琦.人乳头瘤病毒引起子宫颈癌机理和人免疫缺陷病毒的发现:2008年诺贝尔生理学/医学奖评述/中国科学院.2009科学发展报告.北京:科学出版社,2009:112-119.
  • 6Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med, 2009, 360: 1385-1394.
  • 7Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol, 2008, 9 : 929-936.
  • 8WHO Technical Advisory Group. Cancer control: knowledge into action: WHO guide for effective programs. Geneva: World Health Organization, 2006.
  • 9World Health Organization. The 58th World Health Assembly approved resolution on cancer prevention and control. Geneva: World Health Organization, 2005.

同被引文献22

  • 1GUO Hui,ZHANG Qing-yu,SHI Yao,WANG Da-hui,DING Shu-ying,YAN Sha-sha.Characterization of on-road CO, HC and NO emissions for petrol vehicle fleet in China city[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2006,7(7):532-541. 被引量:10
  • 2靳光付,胡志斌,马红霞,霍翔,陈文森,陈峰,徐耀初,沈洪兵.肿瘤家族史和吸烟在肺癌发生中的交互作用研究[J].中华流行病学杂志,2006,27(12):1095-1096. 被引量:16
  • 3邹全明.幽门螺杆菌疫苗的研究进展[J].胃肠病学,2007,12(9):567-570. 被引量:19
  • 4TOTA J E, RAMANA KUMAPt A V, EL KHATIB Z, et al. The road ahead for cervical cancer prevention and control [ J ]. Curt Oncol, 2014, 21 (2) : e255 - e264.
  • 5ARVATZ G, SHAFAT I, LEVY ADAM F, et al. The heparanase system and tumor metastasis: is heparanase the seed and soil? [J]. Cancer Metastasis Rev, 2011, 30(2) : 253 -268.
  • 6LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial- mesenchymal transition [ J ]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
  • 7LI J, HUANG R, SCHMIDT J E, et al. Epidemiological features of Human Papillomavirus (HPV) infection among women living in China's Mainland[J]. Asian Pac J Cancer Prey, 2013, 14(7): 4015 -4023.
  • 8CHEN Q, FEI J, WU L, et al. Detection of cathepsin B, cathep- sin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients [J]. OncolLett, 2011, 2(4): 693 -699.
  • 9JAGODIC M, VRHOVEC I, BORSTNAR S, et al. Prognostic and predictive value of cathepsins D and L in operable breast cancer patients[J]. Neoplasma, 2005, 52(1 ) : 1 -9.
  • 10SULLIVAN S, TOSETrO M, KEVANS D, et al. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer[ J]. Int J Cancer, 2009, 125 (1): 54 -61.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部